My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Ann Palliat Med. 2019 Feb 23;:
Lancet Oncol. 2019 Feb;20(2):e103-e111
Health Rep. 2018 Dec 19;29(12):21-25
Radiother Oncol. 2017 Nov;125(2):175-177
Jpn J Clin Oncol. 2017 Oct 25;:1-4
Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
Int J Radiat Oncol Biol Phys. 2017 Aug 01;98(5):1116-1123
The TNM classification of malignant tumours-towards common understanding and reasonable expectations.
Lancet Oncol. 2017 Jul;18(7):849-851
Am Soc Clin Oncol Educ Book. 2017;37:395-402
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy.
Radiother Oncol. 2017 Apr 20;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)